Comparison of an Automated Thermodynamic Treatment System (LipiFlow) and Warm Compresses for the Treatment of Moderate Severity of Meibomian Gland Dysfunction

Main Article Content

Wipawee Booranapong
http://orcid.org/0000-0002-8812-0319
Pinnita Prabhasawat
http://orcid.org/0000-0002-3801-6978
Suksri Chotikavanich
http://orcid.org/0000-0002-5973-643X
Sasima Tongsai
http://orcid.org/0000-0002-2310-8888
Patsathorn Naranunn
http://orcid.org/0000-0002-0651-0330
Wilaipun Thaweerattanasilp
http://orcid.org/0000-0002-5949-547X
Panida Kosrirukvongs
http://orcid.org/0000-0003-0602-4786

Abstract

Objective: To compare the efficacies of a single thermodynamic treatment system (LipiFlow®) and warm compresses used for 3 months in patients with a moderate severity of meibomian gland dysfunction (MGD).    
Methods: This prospective, randomized, controlled clinical study enrolled 28 patients (22 females, 6 males; mean age, 53.9 ± 14.8 years) diagnosed as having moderate MGD by plugging at the meibomian gland orifices between one-third and two-thirds of lid margins and at least one of the following: a Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire score of 6-12;  a lipid layer thickness (LLT) score of 40-70 Interferometric Color Units; upper eyelid meiboscore of 1-2; and 3-6 expressible meibomian glands (EMGs) in the lower eyelid. Both eyes of each patient were randomized into study and control eyes. Study eyes were treated with a single, 12-minute LipiFlow® system, while control eyes received 5-minute warm compresses twice daily for 3 months. The dry eye symptoms, the number of EMGs, and LLTs were evaluated.
Results: There were no significant differences in the dry eye symptoms, number of EMGs, and LLTs for both groups at baseline and at each follow-up. However, the total SPEED scores for the LipiFlow® group reduced significantly from baseline at each follow-up until 6 months. As to the warm compress group, the total SPEED scores reduced significantly from baseline at each follow-up until 3 months.
Conclusion: The single LipiFlow® treatment and twice-daily warm compresses relieved the dry eye symptoms of patients with a moderate severity of MGD compared with their baseline symptoms, despite no statistical differences in the dry eye symptoms, number of EMGs, and LLTs of both treatments. 

Downloads

Download data is not yet available.

Article Details

How to Cite
Booranapong, W., Prabhasawat, P., Chotikavanich, S., Tongsai, S., Naranunn, P., Thaweerattanasilp, W., & Kosrirukvongs, P. (2019). Comparison of an Automated Thermodynamic Treatment System (LipiFlow) and Warm Compresses for the Treatment of Moderate Severity of Meibomian Gland Dysfunction. iriraj edical ournal, 72(1), 79-86. https://doi.org/10.33192/Smj.2020.11
Section
Original Article

References

1. Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 2011;52:1922-9.
2. Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II epidemiology report. Ocul Surf 2017;15:334-65.
3. Goto E, Endo K, Suzuki A, Fujikura Y, Tsubota K. Improvement of tear stability following warm compression in patients with meibomian gland dysfunction. Adv Exp Med Biol 2002;506:1149-52.
4. Olson MC, Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction. Eye Contact Lens 2003;29:96-9.
5. Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment of meibomian gland dysfunction. Adv Exp Med Biol 1994;350:293-8.
6. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res 2004;78:347-60.
7. Korb DR, Blackie CA. Restoration of meibomian gland functionality with novel thermodynamic treatment device: a case report. Cornea 2010;29:930-3.
8. Majmudar PA; LipiFlow Study Group. A Novel Thermal pulsation treatment for obstructive meibomian gland dysfunction: applying heat to the inner eyelid surfaces. Invest Ophthalmol & Vis Sci 2010;51:6281.
9. Friedland BR, Fleming CP, Blackie CA, Korb DR. A novel thermodynamic treatment for meibomian gland dysfunction. Curr Eye Res 2011;36:79-87.
10. Greiner JV; LipiFlow Study Group. Treatment of meibomian gland dysfunction (MGD) with the novel LipiFlow® thermal pulsation system restores meibomian gland function. Invest Ophthalmol & Vis Sci 2010;51:6282.
11. Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR, et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea 2012;31:396-404.
12. Korb DR, Blackie CA. Case report: a successful LipiFlow treatment of a single case of meibomian gland dysfunction and dropout. Eye Contact Lens 2013;39:e1-e3.
13. Finis D, Hayajneh J, König C, Borrelli M, Schrader S, Geerling G. Evaluation of an automated thermodynamic treatment (LipiFlow®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Ocul Surf 2014;12:146-54.
14. Blackie CA, Coleman CA, Nichols KK, Jones L, Chen PQ, Melton R, et al. A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day. Clin Ophthalmol 2018;12:169-83.
15. Hagen KB, Bedi R, Blackie CA, Christenson-Akagi KJ. Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction. Clin Ophthalmol 2018;12:161-8.
16. Finis D, König C, Hayajneh J, Borrelli M, Schrader S, Geerling G. Six-month effects of a thermodynamic treatment for MGD and implications of meibomian gland atrophy. Cornea 2014;33:1265-70.
17. Greiner JV. A single LipiFlow® thermal pulsation system treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res 2012;37:272-8.
18. Greiner JV. Long-term (12-month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment. Clin Experiment Ophthalmol 2013;41:524-30.
19. Blackie CA, Coleman CA, Holland EJ. The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye. Clin Ophthalmol 2016;10:1385-96.
20. Ngo W, Situ P, Keir N, Korb D, Blackie C, Simpson T, et al. Psychometric properties and validation of the standard patient evaluation of eye dryness questionnaire. Cornea 2013;32:1204-10.
21. Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea 2008;27:1142-7.
22. Blackie CA, Solomon JD, Scaffidi RC, Greiner JV, Lemp MA, Korb DR. The relationship between dry eye symptoms and lipid layer thickness. Cornea 2009;28:789-94.
23. Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology 2008;
115:911-5.
24. Korb DR, Herman JP, Greiner JV, Scaffidi RC, Finnemore VM, Exford JM, et al. Lid wiper epitheliopathy and dry eye symptoms. Eye Contact Lens 2005;31:2-8.
25. Zhao Y, Veerappan A, Yeo S, Rooney DM, Acharya RU, Tan JH, et al. Clinical trial of thermal pulsation (LipiFlow) in meibomian gland dysfunction with preteatment meibography. Eye Contact Lens 2016;42:339-46.
26. Finis D, Pischel N, Schrader S, Geerling G. Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for meibomian gland dysfunction. Cornea 2013;32:1549-53.
27. Michee S, Rabut G, Baudouin C, Labbe A. Treatment of meibomian gland disease with the Lipiflow® system: A prospective study. Acta Ophthalmol 2013; 91:0.
28. Greiner JV. Long-term (3 year) effects of a single LipiFlow thermal pulsation system treatment on meibomian gland function and dry eye symptoms. Eye Contact Lens 2016; 42:99-107.
29. Satjawatcharaphong P, Ge S, Lin MC. Clinical outcomes associated with thermal pulsation system treatment. Optom Vis Sci 2015;92:e334-41.

Most read articles by the same author(s)